BioHarvest Sciences Inc(US:BHST) ZACKS·2026-03-31 21:55分组1 - BioHarvest Sciences Inc. reported a quarterly loss of $0.1 per share, which was better than the Zacks Consensus Estimate of a loss of $0.11, representing an earnings surprise of +4.76% [1] - The company posted revenues of $9.07 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 2.93%, compared to revenues of $7.28 million a year ago [2] - The stock has underperformed the market, losing about 17.7% since the beginning of the year, while the S&P 500 declined by 7.3% [3] 分组2 - The current consensus EPS estimate for the coming quarter is -$0.11 on revenues of $10.59 million, and for the current fiscal year, it is -$0.11 on revenues of $49.04 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is currently in the bottom 40% of over 250 Zacks industries, indicating potential underperformance compared to the top 50% of ranked industries [8]